Form 4: New Enterprise Associates 15, L.P. Acquires Warrants in NeueHealth, Inc.
SEC Form 4 Filing
New Enterprise Associates 15, L.P. reports acquisition of warrants in NeueHealth, Inc. on October 1, 2024.
Summary
- New Enterprise Associates 15, L.P., along with related entities, filed a Form 4 detailing changes in beneficial ownership of NeueHealth, Inc. securities.
- The report indicates the acquisition of 61,865 warrants with an exercise price of $0.01 on October 1, 2024.
- These warrants, exercisable until April 30, 2029, are related to a Warrantholders Agreement and Credit Agreement involving NeueHealth.
- The reporting entities include New Enterprise Associates 15, L.P. (NEA 15), NEA Partners 15, L.P., and NEA 15 GP, LLC, along with individual managers.
- NEA 15 directly holds 185,594 shares of common stock.
- The Indirect Reporting Persons disclaim beneficial ownership of the securities held by NEA 15 in which they have no pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It reflects a transaction but doesn't inherently indicate positive or negative sentiment about the company's performance.
Positives
- The acquisition of warrants by a significant investor like New Enterprise Associates could be seen as a positive signal for NeueHealth, indicating confidence in the company's future prospects.
Risks
- The filing itself doesn't inherently present risks, but the underlying agreements (Warrantholders Agreement and Credit Agreement) could contain terms that pose risks to NeueHealth if not managed effectively.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by significant shareholders, directors, and officers, providing transparency to the market.
Stakeholder Impact
- The acquisition of warrants by a major investor could increase investor confidence.
Key Dates
| Date | Description |
|---|---|
| 2023-08-04 | Date of the Credit Agreement between the Issuer and the lenders thereto. |
| 2023-10-02 | Date of Incremental Amendment No. 1 to the Credit Agreement. |
| 2024-04-08 | Date of the Warrantholders Agreement between the Issuer and the holders listed on Schedule 1 thereto, and Incremental Amendment No. 2 to the Credit Agreement. |
| 2024-10-01 | Date of the transaction (acquisition of warrants). |
| 2024-10-02 | Deemed execution date of the transaction. |
| 2024-10-03 | Date of signature of the reporting person. |
| 2029-04-30 | Expiration date of the warrants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.